Clinical Research
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. Jul 7, 2008; 14(25): 4011-4019
Published online Jul 7, 2008. doi: 10.3748/wjg.14.4011
Table 1 Characteristics of studies included in this meta-analysis for calculating diagnostic accuracy of EUS for gastric cancer staging
No.AuthorYear of publicationNo. of patientsType of studyConfirmatory procedure
1Grimm et al[28]1993147ProspectiveSurgery
2Francois et al[29]199629ConsecutiveSurgery
3Schimizu et al[30]1994125ConsecutiveSurgery
4Dittler et al[31]1993254ConsecutiveSurgery
5Ziegler et al[32]1993118ProspectiveSurgery
6Botet et al[33]199150ProspectiveSurgery
7Xi et al[34]200335ProspectiveSurgery
8Caletti et al[35]199142ProspectiveSurgery
9Akahoshi et al[36]198974ProspectiveSurgery
10Tio et al[37]198972ProspectiveSurgery
11Massari et al[38]199699ProspectiveSurgery
12Saito et al[39]1991110ProspectiveSurgery
13Murata et al[40]1988146ProspectiveSurgery
14Hunerbein et al[41]199619ConsecutiveSurgery
15Perng et al[42]199669ConsecutiveSurgery
16Tio et al[43]198975ProspectiveSurgery
17Tio et al[44]198636ProspectiveSurgery
18Shimoyama et al[45]200445ConsecutiveSurgery
19Willis et al[46]2000116ConsecutiveSurgery
20Rosch et al[47]199241ConsecutiveSurgery
21Javaid et al[48]2003112ConsecutiveSurgery
22Potrc et al200682ProspectiveSurgery
Table 2 Accuracy of EUS with confidence intervals to diagnose T and N stages in gastric cancer patients
Pooled sensitivityPooled specificityPooled LR+Pooled LR-Pooled DOR
T188.1% (84.5-91.1)100.0% (99.7-100.0)90.1 (48.9-165.7)0.17 (0.10-0.28)605.6 (296.8-1235.6)
T282.3% (78.2-86.0)95.6% (94.4-96.6)17.3 (10.9-27.5)0.23 (0.17-0.290108.6 (56.6-208.1)
T389.7% (87.1-92.0)94.7% (93.3-95.9)14.3 (10.3-19.8)0.13 (0.08-0.19)144.4 (95.4-218.7)
T499.2% (97.1-99.9)96.7% (95.7-97.6)19.6 (14.1-27.2)0.07 (0.04-0.12)507.8 (247.5-1042.1)
N158.2% (53.5-62.8)87.2% (84.4-89.7)4.1 (2.4-7.1)0.49 (0.41-0.58)9.5 (5.3-16.9)
N264.9% (60.8-68.8)92.4% (89.9-94.4)6.7 (4.1-10.9)0.39 (0.31-0.49)26.6 (13.9-50.7)
Table 3 Accuracy of EUS with confidence intervals to stage gastric cancers over the past two decades
No. of studiesPooled sensitivityPooled specificityPooled LR+Pooled LR-Pooled DOR
T11986 to 19941256.3 % (49.7-62.6)89.1% (85.5-92.1)4.6 (1.6-13.8)0.51 (0.38-0.69)9.3 (2.9-30.1)
1995 to 1999482.2 % (67.9-92.0)100.0 % (97.9-100.0)72.9 (18.2-288.8)0.13 (0.03-0.68)562.5 (92.0-3438.4)
2000 to 1006584.8% (71.1-93.7)100.0% (98.9-100.0)88.9 (25.3-312.4)0.22 (0.13-0.38)428.9 (96.6-1904.9)
T21986 to 19941284.9% (79.8-89.2)96.7% (95.4-97.8)20.5 (14.8-28.4)0.19 (0.13-0.30)207.0 (109.5-391.6)
1995 to 1999474.4% (57.9-87.0)90.9% (85.4-94.8)6.7 (2.5-18.1)0.33 (0.19-0.55)23.7 (5.3-106.2)
2000 to 1006579.5% (70.8-86.5)94.6 % (91.3-96.9)16.8 (5.3-53.8)0.22 (0.12-0.38)79.6 (22.9-277.2)
T31986 to 19941289.6% (86.3-92.3)95.3% (93.6-96.7)15.5 (11.4-21.1)0.12 (0.07-0.22)160.2 (95.5-268.7)
1995 to 1999490.3% (80.1-96.4)91.3% (85.8-95.2)11.1 (3.5-35.4)0.12 (0.06-0.25)93.3 (30.6-284.6)
2000 to 1006589.8% (83.3-94.5)94.8% (91.3-97.2)13.9 (7.7-25.1)0.12 (0.04-0.37)154.7 (55.7-429.5)
T41986 to 19941298.9% (95.9-99.9)97.1% (95.9-98.0)23.3 (14.6-37.4)0.07 (0.04-0.14)626.4 (256.1-1532.5)
1995 to 19994100% (92.5-100.0)95.8% (91.5-98.3)14.3 (7.6-26.9)0.05 (0.01-0.18)441.7 (85.6-2279.1)
2000 to 10063100.0% (87.2-100.0)95.7% (91.9-98.0)16.4 (7.9-33.9)0.07 (0.02-0.33)260.1 (43.7-1547.4)
N11986 to 19941056.3% (49-62.6)89.1% (85.5-92.1)4.6 (1.6-13.6)0.5 (0.4-0.7)9.3 (2.9-30.1)
1995 to 1999464.6% (53.3-74.9)83.5% (74.9-90.1)3.6 (2.3-5.6)0.5 (0.4-0.6)8.8 (4.3-18.1)
2000 to 2006557.8% (49.0-66.20)85.5% (79.3-90.4)4.4 (2.9-6.6)0.5 (0.3-0.7)10.2 (4.8-21.8)
N21986 to 19941070.6% (65.4-75.5)94.7% (91.7-96.8)11.0 (4.6-26.6)0.3 (0.2-0.4)63.9 (30.9-132.3)
1995 to 1999470.2% (59.9-79.2)83.2% (74.1-90.1)3.9 (2.5-6.1)0.4 (0.3-0.5)11.7 (5.6-24.1)
2000 to 2006449.0% (40.7-57.30)93.0% (87.5-96.6)6.4 (1.7-24.1)0.6 (0.4-0.7)12.7 (2.9-56.2)